Jump to content
  • BIOPRO BW
  • Healthcare industry
  • Project pages
    • MDR & IVDR
    • Innovation & Startups
BIOPRO BW Logo

Main navigation

  • Start page Start page
  • About us

    About us

    Close Close
    • Team
      • Our authors
    • History and achievements
    • Supervisory Board
    • Career
    • Contact / Travel information
  • Activities

    Activities

    Close Close
    • Start-up support
    • Cooperation initiatives
    • Anlaufstelle Regulatorik Gesundheitswirtschaft BW
    • Internationalisation
  • Projects

    Projects

    Close Close
    • Current projects
      • Forum Health Region Baden-Württemberg
      • Alliance for sustainable medical technology
      • PRECISEU - PeRsonalised medicine Empowerment Connecting Innovation ecoSystems across EUrope
      • HACK-IT-NET - enabling an alpine region Health And Care Knowledge and Innovation Transfer NETwork
    • General Projects
      • LinkHealth@BW
    • Completed projects
      • MDR & IVDR Fast-Track Support BW
      • Photon-Counting (PC)-CT Consortium
      • Health Data Scenarios
      • Baden-Württemberg-Center for Academic Drug Discovery
      • Post-Brexit
      • MDR & IVDR Competence Centre BW (MIK)
      • The Phytopharmaceuticals and Valuable Plant Ingredients initiative
      • Advanced Imaging Utilization by Digital Data Application in Baden-Württemberg (PC3-AIDA)
  • Services

    Services

    Close Close
    • Funding
    • Research institutions
    • Healthcare industry database
    • Job market
    • Newsletter
    • Stay in touch with us!
  • Information

    Information

    Close Close
    • Press releases & contact
    • Publications
  • Events

    Events

    Close Close
  • de
  • en
Show menu Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Baden-Württemberg AI Alliance - 08/04/2025 There are two large computer screens on a desk with a computer mouse and keyboard. The screens show a stylized human head and a head in which parts of the brain structure are stylized. They are surrounded by a network.

    Achieving widespread use of AI

    Artificial intelligence presents both opportunities and risks. The Baden-Württemberg AI Alliance is dedicated to fostering collaboration among AI stakeholders to ensure that AI solutions deliver tangible benefits to citizens and businesses across the state. The alliance will also place greater emphasis on advancing AI applications within the healthcare sector.

    https://www.gesundheitsindustrie-bw.de/en/article/news/achieving-widespread-use-ai
  • Detecting drug resistance of tumour cells - 25/05/2023 The picture shows microscope images of model cell lines.

    AI-assisted diagnostics declares war on lung cancer

    Lung cancer is one of the most common cancers and has a particularly high mortality rate. A significant challenge in treating this disease lies in the resistance of lung tumours to conventional drug therapies, rendering chemotherapy ineffective. There is hope on the horizon as a team of experts from Baden-Württemberg has joined forces to develop an innovative AI-supported test procedure that paves the way for individualised therapy approaches.

    https://www.gesundheitsindustrie-bw.de/en/article/news/ai-assisted-diagnostics-declares-war-lung-cancer
  • Vicinity Bio: Optimisation of cancer diagnostics - 27/11/2024 Das Bild zeigt eine mikroskopische Aufnahme eines Gewebes. Die Aufnahme ist bunt und unterschiedliche Zelltypen lassen sich deutlich erkennen.

    Comprehensive histological diagnostics through high-dimensional imaging and artificial intelligence

    Microscopic examination of tissue samples is essential, particularly in tumour diagnostics. The Tübingen-based company Vicinity Bio leverages cutting-edge imaging technologies combined with machine learning to generate comprehensive datasets of individual cells from tissue sections. This approach not only helps identify more targeted therapies but also enhances our understanding of cellular functions and processes within tissues and tumours.

    https://www.gesundheitsindustrie-bw.de/en/article/news/Comprehensive-histological-diagnostics-through-high-dimensional-imaging-and-artificial-intelligence
  • Project SMARTGAIT - 13/09/2023 You can see a test subject whose skeletal position is visualized while walking with the help of colored markers.

    Safe and cost-effective analysis of neurological gait disorders with AI

    Stroke, Parkinson's disease and multiple sclerosis often resulting in gait disorders in those affected. Gait analyses play a crucial role in the successful evaluation and therapy of such disorders. Current measurement methods are costly and time-consuming. The SMARTGAIT project is therefore developing an innovative AI-based system aimed at performing meaningful gait analyses with the help of simple smartphone video recordings.

    https://www.gesundheitsindustrie-bw.de/en/article/news/safe-and-cost-effective-analysis-neurological-gait-disorders-ai
  • Automated pain recognition - 25/01/2023 Two men standing in front of a white wall

    Using artificial intelligence to improve pain management

    Psychologists from Ulm and their cooperation partners have developed algorithms for automated pain recognition in order to be able to dose painkillers more precisely. The researchers are now looking for industrial partners to take their project to application.

    https://www.gesundheitsindustrie-bw.de/en/article/news/using-artificial-intelligence-improve-pain-management
  • Intelligent Diagnostics - 09/02/2022 Nahaufnahme einer Armunterseite mit Pigmentflecken, auf der – als Teil einer multispektralen Aufnahme – das bläuliche, strichcodeartige Projektionsmuster für eine Wellenlänge zu sehen ist.

    AI for added value in digital melanoma diagnostics

    Intelligent Diagnostics is an interdisciplinary project that brings together the latest technologies and research institutes to better support doctors in diagnosing skin cancer through innovative imaging and artificial intelligence.

    https://www.gesundheitsindustrie-bw.de/en/article/news/ai-added-value-digital-melanoma-diagnostics
  • Digitalisation - 04/08/2021 A man holds the examination device towards the face of a seated patient; on the smartphone the photo of the eye background.

    Eye check for all - quick and easy thanks to artificial intelligence

    Many eye diseases are already easily treatable, if they are detected in time. But waiting months for an ophthalmologist’s appointment seems to be the norm - that is, if you can get to see a specialist at all. The Tübingen-based start-up eye2you wants to improve this situation: it has developed a mobile retinal examination device involving a smartphone and AI. It can be used by family doctors, diabetologists and nursing staff and thus help to…

    https://www.gesundheitsindustrie-bw.de/en/article/news/eye-check-all-quick-and-easy-thanks-artificial-intelligence
  • microRNA as a prognostic biomarker - 13/01/2022 Screen of an ECG device showing the typical action potentials of the heart muscle.

    Heart attack diagnosis: fast and unambiguous thanks to artificial intelligence

    People that arrive in emergency rooms with chest pain require swift action in order to rule out a heart attack or to initiate vital life-saving therapy. However, despite many advances, current tests are not yet optimal: they either take hours or produce false-positive results. Researchers at Heidelberg University Hospital are now using AI in an approach that takes microRNAs from a blood sample to specifically diagnose ‘acute coronary syndrome’.

    https://www.gesundheitsindustrie-bw.de/en/article/news/heart-attack-diagnosis-fast-and-unambiguous-thanks-artificial-intelligence
  • Workplace of the future - 10/08/2021 Prototype image of a body support system that fixes a person at the abdomen and hips

    Intelligent body support system for surgery staff

    Operating room staff often spend hours in strenuous postures, which has a significant impact on concentration and quality of work. While operating room equipment is increasingly networked, state-of-the-art medical technology, conditions for operating room staff trail way behind. The start-up company Hellstern medical offers an effective solution for serious pain, fatigue and incorrect interventions.

    https://www.gesundheitsindustrie-bw.de/en/article/news/intelligent-body-support-system-surgery-staff
  • Company profile: medicalvalues GmbH - 05/05/2022 Laptop mit einer Software-Oberfläche, die in Weiß und teilweise in Violet gehalten ist.

    medicalvalues – best possible diagnostics thanks to AI

    The Karlsruhe-based start-up medicalvalues GmbH wants to use its platform to bring together different clinical data sets and thus enable comprehensive medical diagnostics. Artificial intelligence featuring innovative diagnostic algorithms is used to evaluate the data and generate new insights for laboratories and hospitals.

    https://www.gesundheitsindustrie-bw.de/en/article/news/medicalvalues-best-possible-diagnostics-thanks-ai
  • PixelBiotech GmbH - 27/07/2021 Teaser_HuluFISH_7_color_med.jpg

    Searching for tracks with cytogenetics and AI

    The startup Pixelbiotech combines fluorescence techniques with artificial intelligence to detect DNA and RNA in medical samples. HuluFISH is the name of the method, which allows for countless applications - from detecting viral infections, such as COVID-19 or African swine fever virus, to the quality control of gene and immunotherapeutic procedures in cancer medicine.

    https://www.gesundheitsindustrie-bw.de/en/article/news/searching-tracks-cytogenetics-and-ai
  • Dossier - 08/09/2026 The image shows the upper body of a person wearing a lab coat and a stethoscope, with a heart drawn in their open hands, featuring medical symbols.

    AI and robotics are shaping the future of medicine

    Artificial intelligence and robotics are playing an increasingly important role in healthcare, as in many other areas of life. They offer considerable potential to improve medical care, but require an ethically responsible approach.

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/ai-and-robotics-are-shaping-future-medicine
  • Event - 06/11/2026 HIN-logo_1.png

    Health Innovation Nexus

    Strasbourg, France, Registration deadline: 23/10/2026
    https://www.gesundheitsindustrie-bw.de/en/event/health-innovation-nexus-en
  • Event - 03/11/2026 - 05/11/2026

    Trinational Health Tech Days 7

    Strasbourg, France and online, Conference and networking event
    https://www.gesundheitsindustrie-bw.de/en/event/trinational-health-tech-days-7-en
  • Press release - 03/09/2026

    ERC Starting Grant for Heidelberg Neurologist and Neuroscientist Dr. Dr. Varun Venkataramani

    Cells of the highly aggressive brain tumor glioblastoma exhibit predatory behavior: they exploit signaling between healthy neurons and internalize portions of their contact sites. Dr. Dr. Varun Venkataramani of the Heidelberg Medical Faculty of Heidelberg University, and his research team, will investigate how glioblastoma cells benefit from this process and whether it may represent a novel therapeutic target.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/erc-starting-grant-heidelberg-neurologist-and-neuroscientist-dr-dr-varun-venkataramani
  • Press release - 03/09/2026

    Triple ERC Success at the German Cancer Research Center

    Three researchers at the German Cancer Research Center (DKFZ) have each been awarded a Starting Grant from the European Research Council (ERC) this year. Daniel Kirschenbaum, Lena Kutscher, and Michael Scherer impressed the ERC with their innovative research approaches to fundamental questions in cancer medicine.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/triple-erc-success-german-cancer-research-center
  • Press release - 28/08/2026

    Outstanding success for Ulm’s quantum physics QuantERA funds four teams

    Research into quantum technology by four teams at Ulm University is being funded as part of the European QuantERA programme. This is more than at any other German university. The projects focus, for example, on more robust quantum computers and innovative medical diagnostic methods.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/outstanding-success-ulms-quantum-physics-quantera-funds-four-teams
  • Press release - 08/09/2026

    Quality Over Quantity: New Insights into the Role of Specific CAR T Cells in Cancer Therapy

    CAR T-cell therapies are used successfully to treat certain blood cancers. However, while some patients respond even to low-dose treatment, others derive no benefit. Researchers from the Heidelberg Faculty of Medicine at Heidelberg University and the Berlin Institute of Health at Charité (BIH) investigated the reasons behind these differences in a collaborative research project.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/quality-over-quantity-new-insights-role-specific-car-t-cells-cancer-therapy
  • Press release - 08/09/2026

    Heisenberg Professorship for Aurélie Ernst

    With funding from the German Research Foundation’s (DFG) Heisenberg Program, DKFZ researcher Aurélie Ernst aims to investigate how massive changes in the genome contribute to the development of cancer. Her research focuses on a phenomenon known as chromothripsis - a catastrophic event in the genome in which chromosomes break apart and are reassembled incorrectly.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/heisenberg-professorship-aurelie-ernst
  • Find the specialist you are looking for

    Team

    https://www.bio-pro.de/en/biopro/team
  • Dossier - 12/10/2022 Icon heart with ecg line on a green background

    The health sector must become greener

    Worldwide, the health sector is struggling with the consequences of global warming, but fatally is itself responsible for a significant proportion of greenhouse gas emissions. Studies show that hospitals and rehabilitation clinics in particular have great potential for reducing these emissions and, like the manufacturing industry, need to fundamentally revise established processes.

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/health-sector-must-become-greener-1
  • Press release - 10/09/2026

    New collaboration on DNA nanotechnology

    Prof. Chunhai Fan, who is a recipient of the Humboldt Research Award, has been conducting research at the University of Stuttgart since June. Fan works closely with Prof. Laura Na Liu of the 2nd Physics Institute. Both researchers are among the world's leading experts in the field of DNA nanotechnology.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-collaboration-dna-nanotechnology
  • Press release - 09/09/2026

    International Research on Bioengineering of the Mitochondrial Genome

    While the cell nucleus contains almost all of the genome, the mitochondria – the powerhouses of the cell – have their own small genetic code. It consists of only 37 genes, which are organized in circular DNA – mtDNA, for short. Defects in the mitochondrial genome are related to incurable neurodegenerative and metabolic diseases, cancer and also aging processes.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/international-research-bioengineering-mitochondrial-genome
  • Event - 06/10/2026 - 08/10/2026

    Introduction to Planetary Protection

    Stuttgart, Workshop
    https://www.gesundheitsindustrie-bw.de/en/event/introduction-planetary-protection-en
  • Use of health data - 22/09/2026 Ein Bild in den Farben blau und grün, das in der Mitte den Kopf eines Babys zeigt. Darunter eine Karte mit einem Blutstropfen und Verschaltungen eines neuronalen Netzes einer KI.

    The digital twin – shaping the future of neonatal medicine

    Virtually every newborn undergoes routine screening shortly after birth to detect congenital disorders. These examinations have generated a unique wealth of data on early childhood development. However, for many years this valuable resource remained largely untapped. That all changed when researchers in Heidelberg started to use the data to develop a digital twin for newborns. Today, the technology is on the verge of entering clinical practice.

    https://www.gesundheitsindustrie-bw.de/en/article/news/digital-twin-shaping-future-neonatal-medicine
  • EU-wide networking of innovation ecosystems for personalised healthcare

    PRECISEU - PeRsonalised medicine Empowerment Connecting Innovation ecoSystems across EUrope

    https://www.bio-pro.de/en/projects/current-projects/preciseu-personalised-medicine-empowerment-connecting-innovation-ecosystems-across-europe
  • Press release - 16/09/2026

    Professor Jakob Nikolas Kather Appointed Hopp Foundation Professor of “Artificial Intelligence in Medicine” and Founding Director of the New Institute for Medical AI (IMAI) in Heidelberg

    Effective 1 October 2026, Professor Jakob Nikolas Kather will assume the Hopp Foundation Professorship for “Artificial Intelligence in Medicine” at the Heidelberg Faculty of Medicine at Heidelberg University. Associated with the professorship is the establishment of the new Institute for Medical AI (IMAI) at Heidelberg University Hospital, which Professor Kather will lead as its founding director.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/professor-jakob-nikolas-kather-appointed-hopp-foundation-professor-artificial-intelligence-medicine-and-founding-director-new-in
  • Press release - 17/09/2026

    New technique could make MRI more precise

    A team of researchers at the University of Stuttgart has developed a new method that could make MRI even more precise by eliminating “dead time,” a key limiting factor in the measurement process, thereby enabling the detection of signals that are lost using conventional methods. This method opens up new possibilities for medical diagnostics and non-destructive materials testing. The research team presents the new approach in Science Advances.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-technique-could-make-mri-more-precise
  • Press release - 23/09/2026

    ViferaXS Raises €12 Million to Advance Phase II Trial in Chronic Lymphocytic Leukemia and Expand Its Oncology Pipeline

    ViferaXS, a clinical-stage biotechnology company developing peptide-based cancer immunotherapy for hematologic malignancies and solid tumors, today announced the close of the Series A financing round of up to €12 million, including grant funding. The round was led by SPRIND, the German Federal Agency for Breakthrough Innovation, and Huma, with participation from private investors.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/viferaxs-raises-euro-12-million-advance-phase-ii-trial-chronic-lymphocytic-leukemia-and-expand-its-oncology-pipeline
  • Press release - 25/09/2026

    Heidelberg University with Top Placings in latest Shanghai Subject Ranking

    With clinical medicine and medical technology Heidelberg University is again among the best players in Medical Sciences worldwide. In the Global Ranking of Academic Subjects 2026 clinical medicine rose by one place over last year to rank 17th internationally in clinical medicine and so leads the field in Germany. Medical technology is in 21st place internationally and continues to be ranked third in Germany.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/heidelberg-university-top-placings-latest-shanghai-subject-ranking
  • A revolution in glass processing technology for the medical technology sector - 07/10/2026 Rectangular glass plate with numerous convex, lens-shaped structures viewed under a microscope.

    The Freiburg-based start-up Glassomer is rethinking materials

    Glassomer has developed an innovative process for producing pure quartz glass. The result is geometrically complex glass components with micrometre-level precision that can be reproduced consistently at a fraction of the energy cost of conventional glass-melting processes. The company focuses in particular on customised products for diagnostic, therapeutic and microfluidic applications.

    https://www.gesundheitsindustrie-bw.de/en/article/news/freiburg-based-start-glassomer-rethinking-materials
  • Press release - 01/10/2026

    New AI Agent to Capture and Analyze Patient Experiences for Healthcare Delivery and Health Systems

    An international consortium led by researchers at the Heidelberg Faculty of Medicine at Heidelberg University will develop an AI-powered interactive assistant for the analysis of patient experiences over the next four years. The goal is to identify individual burdens and challenges early and comprehensively and make this information actionable for patients, care teams, and health systems.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-ai-agent-capture-and-analyze-patient-experiences-healthcare-delivery-and-health-systems
  • Event - 24/02/2027 - 25/02/2027

    Aktuelle Trends im Biomanufacturing – Erfolgsmodell Kooperation

    Ulm, Congress/Symposium
    https://www.gesundheitsindustrie-bw.de/en/event/aktuelle-trends-im-biomanufacturing-erfolgsmodell-kooperation-en
  • Press release - 30/09/2026

    How cells pass on regulatory information

    A project funded by the Baden-Württemberg Stiftung at the Max Planck Institute of Immunobiology and Epigenetics in Freiburg is investigating the interplay between RNA modifications and epigenetic mechanisms during cell division – and its potential significance for treatment resistance in cancer.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-cells-pass-regulatory-information
  • Press release - 06/10/2026

    EXIST funding for xenko start-up team at Ulm University Virtual health platform to encourage more physical activity in the working day

    The start-up xenko has been awarded an EXIST grant of 143,500 € from the Federal Ministry for Economic Affairs and Energy. The team of founders from Ulm University is developing a digital health platform designed to encourage more physical activity in everyday working life through virtual reality. This development is of interest to companies with occupational health management schemes and, in the long term, to the physiotherapy sector as well.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/exist-funding-xenko-start-team-ulm-university-virtual-health-platform-encourage-more-physical-activity-working-day
  • Press release - 24/09/2026

    Enzyme Beads for More Sustainable Chemistry

    Thanks to enzyme-based biocatalysis, an enormous range of pharmaceutical active ingredients and other complex molecules can be synthesized in an environmentally friendly manner. Researchers at the Karlsruhe Institute of Technology (KIT) have now developed a technology that allows to assemble enzymes into millimeter-sized, storable beads. In this process, the enzymes not only act as catalysts but also constitute the beads’ material itself.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/enzyme-beads-more-sustainable-chemistry
  • Event - 13/04/2027 - 15/04/2027 at_2027_5.png

    DMEA 2027

    Munich, Fair
    https://www.gesundheitsindustrie-bw.de/en/event/dmea-2027-en
  • Press release - 05/10/2026

    A Matter of Quantity: A Universal Target for CAR-T Cells Against Cancer

    CAR-T cell therapies have proven successful in treating several types of blood and lymphoid cancers. However, their use in treating other tumors is significantly more challenging, in part because suitable target structures are lacking.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/matter-quantity-universal-target-car-t-cells-against-cancer
  • Event - 13/05/2027 - 15/05/2027

    REHAB 2027

    Karlsruhe, fair
    https://www.gesundheitsindustrie-bw.de/en/event/rehab-2027-en
  • Press release - 05/10/2026

    How blood flow controls liver function

    The liver is organized into distinct zones in which liver cells perform different functions. The blood vessels of the liver play an important role in this spatial organization: the endothelial cells lining the vessels provide signals that instruct neighboring liver cells and help determine their function. But how do endothelial cells know which signals to produce?

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-blood-flow-controls-liver-function
  • Press release - 06/10/2026

    Harnessing Synthetic Cellular Systems as Immune Cell Boosters

    How can cell-based immunotherapies for cancer and autoimmune diseases become more widely available in the long term? The SYNTHIA project is addressing this challenge: The Max Planck Institute for Medical Research and the Fraunhofer Institute for Cell Therapy and Immunology IZI are collaborating on new research approaches to advance the development of cell-based immunotherapies.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/harnessing-synthetic-cellular-systems-immune-cell-boosters
  • Press release - 05/10/2026

    A Matter of Quantity: A Universal Target for CAR-T Cells Against Cancer

    CAR-T cell therapies have proven successful in treating several types of blood and lymphoid cancers. However, their use in treating other tumors is significantly more challenging, in part because suitable target structures are lacking.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/matter-quantity-universal-target-car-t-cells-against-cancer-1
  • Press release - 08/10/2026

    High iron levels may promote the mobility of brain tumor cells

    Iron is essential for healthy cells. Cancer cells also require this trace element. Researchers in Freiburg have now found evidence that high levels of iron directly in the tumor microenvironment promote the spread of certain cells in a particularly aggressive type of brain tumor known as glioblastoma. In the long term, iron metabolism could therefore serve as a target for more precisely influencing particularly invasive tumor cells.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/high-iron-levels-may-promote-mobility-brain-tumor-cells
  • Event - 18/11/2026 Match_Arena_Mediakit_1080_x_1080_px.jpg

    Match Arena

    Stuttgart, Networking Event
    https://www.gesundheitsindustrie-bw.de/en/event/match-arena-en
  • Press release - 16/10/2026

    Epilepsy: AI Aims to Improve Treatment with Brain Pacemakers

    About 250,000 people in Germany live with epilepsy that does not respond adequately to medication. How can their treatment be further improved with a brain pacemaker? As part of the CLOUDIA research project, the Medical Center – University of Freiburg is now collaborating with a medical technology company to develop an AI-supported assistance system for analyzing long-term brain activity data.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/epilepsy-ai-aims-improve-treatment-brain-pacemakers
  • Prime Vector Technologies is developing a new vaccine platform - 20/10/2026 An overview, in blue and red, of the chain of reactions involving DNA, antibodies, immune cells and a family.

    The ORF platform – one virus, many possibilities

    Many vaccines effectively deliver an antigen to the desired target site. But what if, at the same time, the immune system could be specifically orchestrated to build broad and comprehensive protection? This idea led to the development of a novel vector platform based on the Orf virus. The work was carried out by the Tübingen-based start-up Prime Vector Technologies.

    https://www.gesundheitsindustrie-bw.de/en/article/news/orf-platform-one-virus-many-possibilities
  • Press release - 15/10/2026

    Four Million Euros in EU Funding to Improve Prostate Cancer Care

    A European research consortium led by the German Cancer Research Center (DKFZ) aims to fundamentally improve the diagnosis and treatment of prostate cancer using AI agents, big data, and patient-centered clinical decision support. The central goal is to detect aggressive tumors early and accurately, reduce unnecessary interventions, and tailor treatment decisions more closely to the individual patient.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/four-million-euros-eu-funding-improve-prostate-cancer-care
  • Press release - 16/10/2026

    A new approach to osteoporosis treatment Disabling a bone formation inhibiting protein molecule

    How can the human body be stimulated to build more bone, thus helping those affected by osteoporosis? Researchers in Ulm have investigated the role played by the protein molecule Axl in this process. Their efforts were successful: in a study, they demonstrated that Axl inhibits bone formation – and that cells produce significantly more bone tissue when the molecule is blocked using medication. There are no discernible harmful side effects.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-approach-osteoporosis-treatment-disabling-bone-formation-inhibiting-protein-molecule
  • Funding

    GeneNovate | Call for Application 2027

    Funding programme, Funded by: Federal Ministry of Research, Technology and Space, sb_search.searchresult.label.programSubmissionDate: 13/11/2026
    https://www.gesundheitsindustrie-bw.de/en/database/funding/genenovate-call-application-20252026
  • Funding

    GeneNovate | Call for Application 2027

    Funding programme, Funded by: Federal Ministry of Research, Technology and Space, sb_search.searchresult.label.programSubmissionDate: 13/11/2026
    https://www.bio-pro.de/en/service/funding/genenovate-call-application-20252026
  • Press release - 19/10/2026

    New Biotech Master’s Degree Launches at Ulm University: Pharmaceutical and Molecular Biotechnology

    How do RNA-, protein- or stem cell-based therapies work? How can data science methods from bioinformatics and artificial intelligence be used to develop new pharmaceutical active substances? Students at Ulm University are learning this in the new master’s programme in Pharmaceutical and Molecular Biotechnology (PMB).

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-biotech-masters-degree-launches-ulm-university-pharmaceutical-and-molecular-biotechnology
  • Exploit opportunities, mastering challenges EP_Logo_cmyk.jpg

    Post-Brexit

    https://www.bio-pro.de/en/projects/Completed-projects/post-brexit
  • Event - 04/11/2026 73778

    Lunch & Learn ahead of MEDICA: Collaborative R&D funding for healthcare innovation in UK and Germany

    Online (Webex), Registration deadline: 02/11/2026, information event
    https://www.gesundheitsindustrie-bw.de/en/event/lunch-und-learn-ahead-medica-collaborative-r-und-d-funding-healthcare-innovation-uk-and-germany
  • Event - 04/11/2026 73778

    Lunch & Learn ahead of MEDICA: Collaborative R&D funding for healthcare innovation in UK and Germany

    Online (Webex), Registration deadline: 02/11/2026, information event
    https://www.bio-pro.de/en/events/lunch-und-learn-ahead-medica-collaborative-r-und-d-funding-healthcare-innovation-uk-and-germany
  • Robotics in medicine: initial trials of HASEL technology - 04/11/2026 Group photo of a young woman and three men wearing shirts and sweaters, gathered around a projection of the mechanical patient.

    Using artificial muscles to reduce uncontrolled tremors

    For people with tremors, even simple everyday tasks can become a challenge. Researchers from Stuttgart and Tübingen are developing a novel assistive system designed to actively suppress these involuntary movements. Initial tests using artificial muscles based on HASEL technology have shown promising results – but there is still a long way to go before the technology is ready for everyday use.

    https://www.gesundheitsindustrie-bw.de/en/article/news/using-artificial-muscles-reduce-uncontrolled-tremors
  • Event - 10/12/2026 EU_Week_of_Regions_and_Cities_Session_Image_narrow_EN.png

    From Innovation To Impact: How Alpine Regions Can Build Stronger, Greener And More Digital Health And Care Systems

    Online, Workshop
    https://www.bio-pro.de/en/events/innovation-impact-how-alpine-regions-can-build-stronger-greener-and-more-digital-health-and-care-systems
  • Press release - 29/10/2026

    VUSE XR closes €1.2 million pre-seed round to scale enterprise mixed reality training

    VUSE XR today announced the closing of a €1.2 million pre-seed financing round led by IACD, a Düsseldorf-based business angel network. The company develops the VUSE XR Hub, an enterprise software solution for creating and deploying mixed reality training for industrial and life sciences companies.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/vuse-xr-closes-euro-12-million-pre-seed-round-scale-enterprise-mixed-reality-training
  • Press release - 29/10/2026

    New Approach Could Make Immunotherapy for Blood Cancer More Precise

    Researchers at the Faculty of Medicine – University of Freiburg have developed a new approach to specifically target an aggressive form of blood cancer while better sparing healthy immune cells. In what is known as T-cell acute lymphoblastic leukemia (T-ALL), cancer cells develop from the body’s own immune defense cells. This complicates treatment, as immunotherapies studied to date can also destroy healthy immune cells.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-approach-could-make-immunotherapy-blood-cancer-more-precise
  • Press release - 20/10/2026

    How randomness makes artificial vision more reliable

    Humans are usually remarkably good at recognising objects, even under poor viewing conditions. Artificial vision systems, by contrast, reach their limits more quickly when images are distorted or unfamiliar. Researchers at the Hertie Institute for Clinical Brain Research (HIH) have now investigated what artificial vision systems can learn from the brain.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-randomness-makes-artificial-vision-more-reliable
  • Press release - 26/10/2026

    Multiple sclerosis: New treatment significantly reduces relapses

    A new treatment could improve care for people with relapsing multiple sclerosis (MS). In two international studies involving a total of 2,007 patients, remibrutinib reduced the annualized relapse rate by 31% to 35% compared with an established MS therapy. New inflammatory brain lesions were also significantly less frequent. In addition, there are indications that the treatment may slow the progression of physical disability.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/multiple-sclerosis-new-treatment-significantly-reduces-relapses
  • Press release - 04/11/2026

    Molecular guardian inhibits aggressive brain tumor's ability to switch between identities

    One of the reasons for the high aggressiveness of glioblastomas is their remarkable adaptability. A team led by scientists from the German Cancer Research Center (DKFZ), the EMBL, HITBR*, and the Wellcome Sanger Institute, Cambridge, now describes how glioblastoma cells switch between different states. At the same time, they identified a key factor that, acting as a guardian of cell identity, limits this adaptability.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/molecular-guardian-inhibits-aggressive-brain-tumors-ability-switch-between-identities
  • Event - 18/11/2026 73778

    BW-UK networking evening at MEDICA 2026

    Baden-Württemberg joint booth G24 in hall 15, trade-fair MEDICA, Registration deadline: 16/11/2026, Messe
    https://www.gesundheitsindustrie-bw.de/en/event/bw-uk-networking-evening-medica-2026
  • Event - 18/11/2026 73778

    BW-UK networking evening at MEDICA 2026

    Baden-Württemberg joint booth G24 in hall 15, trade-fair MEDICA, Registration deadline: 16/11/2026, Messe
    https://www.bio-pro.de/en/events/bw-uk-networking-evening-medica-2026

Page 21 / 21

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • About us
    • Team
    • History and achievements
    • Supervisory Board
    • Career
    • Contact / Travel information
  • Activities
    • Start-up support
    • Cooperation initiatives
    • Anlaufstelle Regulatorik Gesundheitswirtschaft BW
    • Internationalisation
  • Projects
    • Current projects
    • General Projects
    • Completed projects
  • Services
    • Funding
    • Research institutions
    • Healthcare industry database
    • Job market
    • Newsletter
    • Stay in touch with us!
  • Information
    • Press releases & contact
    • Publications
  • Events
  • Project pages
    • MDR & IVDR
    • Innovation & Startups
  • Portals
    • BIOPRO BW
    • Healthcare industry
  • To top

stay informed

Newsletter abonnieren

Social Media

  • Xing Xing
  • Twitter visit Twitter
  • LinkedIn visit LinkedIn
  • Rss visit RSS
  • Privacy statement
  • Accessability Declaration
  • Legal notice
  • Sitemap
  • Contact
© 2026
Website address: https://www.bio-pro.de/en/search